How close are we to breach?
2.78× vs <= 2.90×
0.0×1.0×2.0×2.90×
4% cushion · breach at +$0.35B debt or −16% EBITDA
| Covenant | Headline | Current | Threshold | Cushion | Status |
|---|---|---|---|---|---|
| Debt Incurrence § 4.09 |
4% cushion to the leverage ceiling | 2.78× | <= 2.90× | 4% | Warning |
| Permitted Liens § 4.12 |
1 computable · Plus 49 qualitative lien carve-outs (unlimited / existing / refinancing) — standard HY patterns. | $295M | cap | — | In Compliance |
| Restricted Payments § 4.07 |
Ratio-conditional gate — currently open (unlimited RP) | — | ≤ 2.00× | — | In Compliance |
| Test | Current | Threshold | Cushion | Capacity gauge | Status |
|---|---|---|---|---|---|
| Fixed Charge Coverage Ratio Test
§ Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock [4]provided, however, that the Issuer and any of its Restricted Subsidiaries may Incur Indebtedness (including Acquired Indebtedness) or issue shares of Disqualified Stock and any of the Issuer’s Restricted Subsidiaries may issue shares of Preferred Stock (any such Indebtedness or Disqualified Stock Incurred or issued pursuant to this proviso, the “Ratio Debt”), in each case if (a) other than in the case of Senior Secured Debt, either (x) the Fixed Charge Coverage Ratio of the Issuer and its Restricted Subsidiaries as of the Applicable Test Date does not decrease or is at least 2.00 to 1.00 |
3.28× | >= 2.00× | 39% | In Compliance | |
| Consolidated Total Debt Ratio Test
§ Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock [5]or (y) the Consolidated Total Debt Ratio of the Issuer and its Restricted Subsidiaries as of the Applicable Test Date does not increase or is no greater than 3.15 to 1.00 |
2.65× | <= 3.15× | 16% | Warning | |
| Consolidated Senior Secured Debt Ratio Test
§ Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock [6]or (b) in the case of Senior Secured Debt, the Consolidated Senior Secured Debt Ratio of the Issuer and its Restricted Subsidiaries as of the Applicable Test Date does not increase or is no greater than 2.90 to 1.00 |
2.78× | <= 2.90× | 4% | Warning |
| Clause | Basket | Resolved Cap | Formula | Capacity | Section |
|---|---|---|---|---|---|
| (1) | Credit Agreement Indebtedness | $835M | the greater of (A) 100% of EBITDA as of the Applicable Test Date and (B) €835 million |
$835M cap |
Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock, clause (a) [7](a) the Incurrence by the Issuer or its Restricted Subsidiaries of Indebtedness under any Credit Agreement (and the issuance and creation of letters of credit, guarantees and bankers’ acceptances thereunder (with letters of credit, guarantees and bankers’ acceptances being deemed, for purposes of this clause (a), to have a principal amount equal to the face amount thereof at the time of issuance)) in an aggregate principal amount not to exceed the greater of (A) 100% of EBITDA as of the Applicable Test Date and (B) €835 million; |
| (4) | Purchase Money and Capital Lease Obligations | $295M | the greater of (x) 35% of EBITDA as of the Applicable Test Date and (y) €295 million |
$295M cap |
Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock, clause (d) [13](d) (1) Indebtedness, Capitalized Lease Obligations, finance lease obligations, mortgage financings or purchase money obligations, in each case, Incurred by the Issuer or any of its Restricted Subsidiaries, Disqualified Stock issued by the Issuer or any of its Restricted Subsidiaries and Preferred Stock issued by any Restricted Subsidiaries to finance, all or any part of the acquisition, purchase, lease, construction, rental payments, design, installation, repair, replacement or improvement of property (real or personal), vehicles, plant or equipment or other fixed or capital assets (whether through the direct purchase of assets or the Capital Stock of any Person owning such assets) in an aggregate principal amount, including all Indebtedness Incurred to renew, refund, refinance, replace, defease or discharge any Indebtedness Incurred pursuant to this clause (d)(1), not to exceed the greater of (x) 35% of EBITDA as of the Applicable Test Date and (y) €295 million, outstanding at the time of Incurrence |
| (11) | General Indebtedness Basket | $420M | the greater of (x) 50% of EBITDA as of the Applicable Test Date and (y) €420 million |
$420M cap |
Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock, clause (k) [8](k) Indebtedness, Disqualified Stock or Preferred Stock in an aggregate principal amount or liquidation preference that, when aggregated with the principal amount or liquidation preference of all other Indebtedness, Disqualified Stock and Preferred Stock then outstanding and Incurred pursuant to this clause (k), does not exceed the greater of (x) 50% of EBITDA as of the Applicable Test Date and (y) €420 million |
| (18) | Securitization and Factoring | $210M | the greater of (x) €210 million and (y) 25% of EBITDA as of the Applicable Test Date |
$210M cap |
Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock, clause (r) [9](r) Indebtedness Incurred pursuant to factoring, securitizations, receivables financings or similar arrangements, including by a Special Purpose Securitization Subsidiary in a Permitted Securitization Financing (x) incurred in the ordinary course of business or (y) either (i) with respect to which recourse to the Issuer or any Restricted Subsidiary (other than the Special Purpose Securitization Subsidiaries) in connection with such transactions is limited to the extent customary (as determined by the Issuer in good faith) for similar transactions in the applicable jurisdictions (including Standard Securitization Undertakings and, to the extent applicable, in a manner consistent with the delivery of a “true sale”/”absolute transfer” opinion with respect to any transfer by the Issuer or any Restricted Subsidiary (other than a Special Purpose Securitization Subsidiary)), or (ii) does not exceed the greater of (x) €210 million and (y) 25% of EBITDA as of the Applicable Test Date; |
| (24) | Local lines of credit | $210M | the greater of (x) €210 million and (y) 25% of EBITDA as of the Applicable Test Date |
$210M cap |
Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock, clause (x) [11](x) Indebtedness consisting of local lines of credit, bilateral facilities, working capital or overdraft facilities or other operating facilities either (x) Incurred to finance the working capital needs of the Issuer and its Subsidiaries or (y) in an amount not to exceed the greater of (x) €210 million and (y) 25% of EBITDA as of the Applicable Test Date |
| (29) | Guarantees of Joint Venture obligations | $250M | the greater of (i) €250 million and (ii) 30% of EBITDA as of the Applicable Test Date |
$250M cap |
Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock, clause (cc) [12](cc) Guarantees of the obligations of joint ventures in an aggregate amount not exceeding the greater of (i) €250 million and (ii) 30% of EBITDA as of the Applicable Test Date; |
| Σ Computable basket capacity | $2220M | sum of 6 dollar-quantified clauses | |||
| Clause | Basket | Resolved Cap | Formula | Capacity | Section |
|---|---|---|---|---|---|
| (25) | General Liens Basket | $295M | the greater of (x) €295 million and (y) 35% of EBITDA as of the Applicable Test Date |
$295M cap |
Permitted Liens, clause (25) [14](25) Liens securing obligations which obligations do not exceed the greater of (x) €295 million and (y) 35% of EBITDA as of the Applicable Test Date at any one time outstanding; |
| Clause | Basket | Resolved Cap | Formula | Capacity | Section |
|---|---|---|---|---|---|
| (7) | Investments in Unrestricted Subsidiaries | $125M | the greater of (x) €125 million and (y) 15% of EBITDA as of the Applicable Test Date |
$125M |
Limitation on Restricted Payments, clause (7) [19](7) Investments in Unrestricted Subsidiaries having an aggregate Fair Market Value, taken together with all other Investments made pursuant to this clause (7) that are at that time outstanding, not to exceed the greater of (x) €125 million and (y) 15% of EBITDA as of the Applicable Test Date |
| (8) | General Dividend Basket | $0M | the sum of (a) 7% of the net proceeds received by the Issuer or a Restricted Subsidiary from any Public Offering and (b) an amount equal to the greater of (A) 7% of the Market Capitalization and (B) 7% of the IPO Market Capitalization |
$0M |
Limitation on Restricted Payments, clause (8) [20](8) the payment of dividends or distributions on the common stock of the Issuer, a Parent or the IPO Entity (or a Restricted Payment or the payment of dividends to enable any Parent or the IPO Entity or to fund the payment by any Parent or the IPO Entity of dividends on such entity’s common stock), in an amount not to exceed in any fiscal year the sum of (a) 7% of the net proceeds received by the Issuer or a Restricted Subsidiary (or contributed to the equity of the Issuer or any Restricted Subsidiary (other than through the issuance of Disqualified Stock or through an Excluded Contribution)) from any Public Offering or contributed to the equity of the Issuer or loaned as Subordinated Shareholder Debt to the Issuer or any Restricted Subsidiary and (b) an amount equal to the greater of (A) 7% of the Market Capitalization and (B) 7% of the IPO Market Capitalization; |
| (10) | General Restricted Payments Basket | $210M | the greater of (x) €210 million and (y) 25% of EBITDA as of the Applicable Test Date |
$210M |
Limitation on Restricted Payments, clause (10) [21](10) other Restricted Payments in an aggregate amount not to exceed the greater of (x) €210 million and (y) 25% of EBITDA as of the Applicable Test Date; |
| (21) | Subordinated Debt Repurchase Basket | $170M | the greater of (x) €170 million and (y) 20% of EBITDA as of the Applicable Test Date |
$170M |
Limitation on Restricted Payments, clause (21) [16](21) the redemption, repurchase, defeasance, exchange or other acquisition or retirement of Subordinated Indebtedness or Subordinated Shareholder Debt of the Issuer or any Restricted Subsidiary or any direct or indirect parent of the Issuer in an aggregate amount not to exceed the greater of (x) €170 million and (y) 20% of EBITDA as of the Applicable Test Date; |